Cargando…

新局面下对血液肿瘤药物创新研发的思考

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8770877/
https://www.ncbi.nlm.nih.gov/pubmed/35045665
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2021.12.001
_version_ 1784635466919706624
collection PubMed
description
format Online
Article
Text
id pubmed-8770877
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Editorial office of Chinese Journal of Hematology
record_format MEDLINE/PubMed
spelling pubmed-87708772022-02-13 新局面下对血液肿瘤药物创新研发的思考 Zhonghua Xue Ye Xue Za Zhi 专论 Editorial office of Chinese Journal of Hematology 2021-12 /pmc/articles/PMC8770877/ /pubmed/35045665 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2021.12.001 Text en 2021年版权归中华医学会所有 https://creativecommons.org/licenses/by/3.0/This work is licensed under a Creative Commons Attribution 3.0 License.
spellingShingle 专论
新局面下对血液肿瘤药物创新研发的思考
title 新局面下对血液肿瘤药物创新研发的思考
title_full 新局面下对血液肿瘤药物创新研发的思考
title_fullStr 新局面下对血液肿瘤药物创新研发的思考
title_full_unstemmed 新局面下对血液肿瘤药物创新研发的思考
title_short 新局面下对血液肿瘤药物创新研发的思考
title_sort 新局面下对血液肿瘤药物创新研发的思考
topic 专论
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8770877/
https://www.ncbi.nlm.nih.gov/pubmed/35045665
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2021.12.001
work_keys_str_mv AT xīnjúmiànxiàduìxuèyèzhǒngliúyàowùchuàngxīnyánfādesīkǎo
AT xīnjúmiànxiàduìxuèyèzhǒngliúyàowùchuàngxīnyánfādesīkǎo
AT xīnjúmiànxiàduìxuèyèzhǒngliúyàowùchuàngxīnyánfādesīkǎo
AT xīnjúmiànxiàduìxuèyèzhǒngliúyàowùchuàngxīnyánfādesīkǎo
AT xīnjúmiànxiàduìxuèyèzhǒngliúyàowùchuàngxīnyánfādesīkǎo
AT xīnjúmiànxiàduìxuèyèzhǒngliúyàowùchuàngxīnyánfādesīkǎo